Exploring the potential of nanocarriers in antipsoriatic therapeutics
Psoriasis is an autoimmune disease characterized by erythematous, scaly patches on the skin. It can be effectively managed with topical therapies since they deliver drugs to target sites of disease efficiently and can minimize systemic side-effects while ensuring high patient compliance. However, co...
Main Authors: | Mohammad Shaif, Poonam Kushwaha, Shazia Usmani, Supriya Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-10-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2022.2089616 |
Similar Items
-
Recent Advances in Nanotherapeutics for Multiple Myeloma
by: Daniela Iannazzo, et al.
Published: (2020-10-01) -
Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
by: Silvia Voci, et al.
Published: (2021-03-01) -
Antipsoriatic Potential of Quebecol and Its Derivatives
by: Corinne Bouchard, et al.
Published: (2022-05-01) -
Editorial: Anti-cancer drug delivery: lipid-based nanoparticles
by: Alaaldin M. Alkilany, et al.
Published: (2023-07-01) -
Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI
by: Guanfu Liu, et al.
Published: (2022-12-01)